Tuesday, May 20, 2025

The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Health Policy

Binaytara Nepal Healthcare Policy Debate

This article recaps a 2025 advocacy dialogue led by Binaytara and Dr. Binay Shah to reform Nepal’s health insurance system and expand access to cancer care.

May 13, 2025

By The Cancer News Team

Understanding the Lung Cancer Screening Guidelines

2025-05-12

Melanoma Monday 2025: On Skin Cancer Prevention & Awareness

2025-05-05

Esophageal Cancer Awareness Month: Symptoms, Risks & Prevention

2025-04-24

Implementation Science In Cancer: Where Are We Today?

2025-04-18

Cancer Stigmas: The Invisible Barrier to Cancer Treatment in LMICs

2025-04-10

Health Equity

From Glamor to Reality: How Tobacco Fuels the Lung Cancer Epidemic

This article explores how tobacco use drives the lung cancer epidemic and highlights efforts by Binaytara through CME conferences and the OncoBlast app to address cancer care disparities.

2025-04-01

By The Cancer News Team

Health Equity

March is Multiple Myeloma Awareness Month What You Need to Know

March is Multiple Myeloma Awareness Month, a time to educate, inspire, and support patients and caregivers. Learn about myeloma symptoms, treatment advancements, disparities, and the latest expert insights on managing this blood cancer.

2025-03-21

By The Cancer News Team

New Approvals

The FDA approves a new drug for HER2-positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1

The FDA has approved pembrolizumab in combination with trastuzumab and chemotherapy as a first-line treatment for HER2-positive gastric or GEJ adenocarcinoma expressing PD-L1 (CPS ≥ 1), based on improved survival outcomes in a Phase 3 clinical trial.

2025-03-21

By The Cancer News Team

Research

A New Combination in Kidney Cancer Therapy: High Doses of Seleno-L-Methionine and Axitinib in a Phase I Trial

A Phase I trial explores the safety, efficacy, and tumor-suppressing effects of high-dose Seleno-L-Methionine (SLM) with Axitinib in metastatic clear cell renal carcinoma (mccRCC), showing promising early results.

2025-03-19

By Dr. Yousef Zakharia